Pages that link to "Q44781447"
Jump to navigation
Jump to search
The following pages link to Response criteria for phase II studies of supratentorial malignant glioma (Q44781447):
Displaying 50 items.
- Distribution and radiosensitizing effect of cholesterol-coupled Dbait molecule in rat model of glioblastoma (Q21560786) (← links)
- Procarbazine, lomustine and vincristine for recurrent high-grade glioma (Q24187436) (← links)
- Antiangiogenic therapy for high-grade glioma (Q24193485) (← links)
- Biopsy versus resection for the management of low-grade gliomas (Q24197750) (← links)
- Biopsy versus resection for the management of low-grade gliomas (Q24234687) (← links)
- Anti-angiogenic therapy for high grade glioma (Q24239851) (← links)
- Anti-angiogenic therapy for high grade glioma (Q24240185) (← links)
- Temozolomide for High Grade Glioma (Q24241222) (← links)
- Chemotherapeutic wafers for High Grade Glioma (Q24242222) (← links)
- Practical guidelines for the treatment of malignant gliomas. (Q24537977) (← links)
- Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma (Q24644727) (← links)
- Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors (Q24676928) (← links)
- A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of Sulfasalazine for the treatment of progressing malignant gliomas: study protocol of [ISRCTN45828668]. (Q25257862) (← links)
- High-grade glioma management and response assessment-recent advances and current challenges (Q26740664) (← links)
- Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR Images (Q26743358) (← links)
- Recurrent Glioblastoma: Where we stand (Q26765042) (← links)
- Multimodality Brain Tumor Imaging: MR Imaging, PET, and PET/MR Imaging (Q26796223) (← links)
- Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials (Q26801351) (← links)
- Circulating glioma biomarkers (Q26830329) (← links)
- Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients (Q26853308) (← links)
- Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods (Q26853516) (← links)
- Diagnosis and treatment in neuro-oncology: an oncological perspective (Q26860696) (← links)
- Multifunctional nanoparticles for brain tumor imaging and therapy (Q26865418) (← links)
- Medical management of brain tumors and the sequelae of treatment (Q26992174) (← links)
- Emerging methods for disease monitoring in malignant gliomas (Q27023823) (← links)
- Seizure outcome after radiotherapy and chemotherapy in low-grade glioma patients: a systematic review (Q27027730) (← links)
- Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513. (Q27310843) (← links)
- Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma (Q27344690) (← links)
- A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study (Q27853118) (← links)
- Immunotherapy response assessment in neuro-oncology: a report of the RANO working group (Q28083009) (← links)
- Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis (Q28088458) (← links)
- The basics of diffusion and perfusion imaging in brain tumors (Q28606582) (← links)
- Somatic mutations associated with MRI-derived volumetric features in glioblastoma (Q28607337) (← links)
- The comprehensive neuro-oncology data repository (CONDR): a research infrastructure to develop and validate imaging biomarkers (Q28608269) (← links)
- 3D Slicer as an image computing platform for the Quantitative Imaging Network (Q28727260) (← links)
- DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma (Q28730443) (← links)
- Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma (Q28731328) (← links)
- A novel method for volumetric MRI response assessment of enhancing brain tumors (Q28743259) (← links)
- Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813. (Q30275188) (← links)
- A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients (Q30300114) (← links)
- Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma. (Q30361848) (← links)
- Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review (Q30393860) (← links)
- A novel, reproducible, and objective method for volumetric magnetic resonance imaging assessment of enhancing glioblastoma (Q30408669) (← links)
- Stereotactic LINAC-Radiosurgery for Glomus Jugulare Tumors: A Long-Term Follow-Up of 27 Patients (Q30408851) (← links)
- A randomized trial of bevacizumab for newly diagnosed glioblastoma (Q30410163) (← links)
- Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report (Q30411688) (← links)
- Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study (Q30413713) (← links)
- Perfusion MRI: the five most frequently asked clinical questions (Q30416198) (← links)
- Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? (Q30418915) (← links)
- International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors (Q30426724) (← links)